Seagen Inc. (SGEN) Q3 2021 Earnings Conference Call October 29, 2021 4:30 PM ET
Company Participants
Clay Siegall – President and Chief Executive Officer
Peggy Pinkston – Vice President of Investor Relations
Todd Simpson – Chief Financial Officer
Chip Romp – Executive Vice President-Commercial
Roger Dansey – Chief Medical Officer
Conference Call Participants
Geoff Meacham – Bank of America
Tom Prickett – JPMorgan
Salveen Richter – Goldman Sachs
Aiden – Guggenheim Securities
Kennen Mackay – RBC Capital Markets
Boris Peaker – Cowen
Gena Wang – Barclays
Andy Hsieh – William Blair
Jay Olson – Oppenheimer
Zhiqiang Shu – Berenberg
Ren Benjamin – JMP Securities
Joe Catanzaro – Piper Sandler
Operator
Good afternoon, and welcome to the Seagen Third Quarter 2021 financial results conference call. All participants will be in listen-only mode. [Operator Instructions]. After today's presentation, there will be an opportunity to ask questions. [Operator Instructions]. Please note this event is being recorded. I would now like to turn the conference over to Peggy Pinkston, Vice President of Investor Relations. Please go ahead.
Peggy Pinkston
Thank you, Operator. And good afternoon, everyone. I'm pleased to welcome you to Seagent's third quarter 2021 financial results conference call. This afternoon, we issued a press release with our results and the press release and supporting slides are available on our website in the Investors section, Events and Presentation page. Speakers on today's call will be Clay Siegall, President and Chief Executive Officer, Todd Simpson, Chief Financial Officer, Chip Romp, Executive Vice President-Commercial U.S., and Roger Dansey, Chief Medical Officer. Following our prepared remarks, we'll open the line for questions. We aim to keep this call to 1 hour and so ask that you limit yourselves to 1 question to give everyone an opportunity to participate in Q&A during our call today. Today's conference call will include forward-looking statements regarding future or anticipated events and results, including the Company's 2021 financial outlook, anticipated product sales, revenues, costs
- Read more current SGEN analysis and news
- View all earnings call transcripts